Company news
Treace Medical Concepts, Inc. (NASDAQ:TMCI) news
Treace Medical Concepts, Inc. news releases on 6ix. Latest, Feb 27, 2024: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results…
Press releases — page 2
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
February 26, 2024
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
February 6, 2024
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
February 1, 2024
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
January 7, 2024
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
November 8, 2023
Treace to Report Third Quarter 2023 Financial Results
October 15, 2023
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
September 13, 2023
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
September 10, 2023
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
August 20, 2023
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
August 7, 2023
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 17, 2023
Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer
July 11, 2023
Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System
June 12, 2023
Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries
May 31, 2023
Treace Medical Concepts Reports First Quarter 2023 Financial Results
May 7, 2023
Treace to Report First Quarter 2023 Financial Results on May 8, 2023
April 19, 2023
Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities
April 18, 2023
Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results
March 6, 2023
Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics
March 2, 2023
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
February 26, 2023
Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock
February 6, 2023
Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock
February 6, 2023
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
January 8, 2023
Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents
December 18, 2022
Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology
November 27, 2022
Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study
November 20, 2022
Treace Medical Concepts Reports Third Quarter 2022 Financial Results
November 7, 2022
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
October 17, 2022
Treace Announces Updated ALIGN3D™ Data at the 2022 AOFAS Annual Meeting
September 12, 2022
Treace Medical Concepts Reports Second Quarter 2022 Financial Results
August 8, 2022
Treace Announces Full Commercial Release of New Technologies for Bunion and Related Midfoot Surgery
August 2, 2022
Treace Medical Concepts Reports First Quarter 2022 Financial Results
May 4, 2022
Treace Announces Peer-Reviewed Publication of ALIGN3D™ Multicenter Prospective Clinical Data
May 4, 2022
Treace Secures Up to $150 Million in Debt Financing
May 1, 2022
Treace to Report First Quarter 2022 Financial Results on May 5, 2022
April 13, 2022
Treace Files Patent Infringement Suit To Protect Lapiplasty® Bunion Technology
March 27, 2022
Treace Medical Concepts Reports Fourth Quarter and Full Year 2021 Financial Results
March 2, 2022
Treace Announces Updated ALIGN3D™ Data at the 2022 ACFAS Scientific Conference
February 24, 2022
Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
February 13, 2022
Treace Announces Grant of U.S. Patent on Instrumented Bunion Correction
January 18, 2022
Treace Medical Concepts Provides 2021 Preliminary Sales Results
January 9, 2022
Treace Announces Grant of U.S. Patent and Allowance of U.S. Patent Application on Bone Positioner Technology for Bunion Correction
November 29, 2021
Treace Medical Concepts Reports Third Quarter 2021 Financial Results
November 3, 2021
Treace Announces Grant of Additional U.S. Patent on Instrumented Bunion Correction
October 20, 2021
Treace to Report Third Quarter 2021 Financial Results on November 4, 2021
October 13, 2021
Treace Medical Concepts Appoints New Directors
October 3, 2021
Treace Announces First Patient Treated in Mini3D™ Lapiplasty® Clinical Study
September 30, 2021
Treace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual Meeting
September 22, 2021
Treace Announces Launch of Adductoplasty™ Instrumented Midfoot Correction System
September 12, 2021
Treace Announces New Supportive ALIGN3D™ Data to be Presented at the 2021 AOFAS Annual Meeting
August 31, 2021